DK147086D0 - Farmaceutisk komposition til kombinationsterapi af hormonafhaengige cancertyper - Google Patents

Farmaceutisk komposition til kombinationsterapi af hormonafhaengige cancertyper

Info

Publication number
DK147086D0
DK147086D0 DK147086A DK147086A DK147086D0 DK 147086 D0 DK147086 D0 DK 147086D0 DK 147086 A DK147086 A DK 147086A DK 147086 A DK147086 A DK 147086A DK 147086 D0 DK147086 D0 DK 147086D0
Authority
DK
Denmark
Prior art keywords
cancer types
sex steroid
antiandrogen
inhibitor
combination therapy
Prior art date
Application number
DK147086A
Other languages
English (en)
Other versions
DK168516B1 (da
DK147086A (da
Inventor
Fernand Labrie
Alain Belanger
Andre Dupont
Original Assignee
Fernand Labrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/636,883 external-priority patent/US4775660A/en
Priority claimed from US06/699,702 external-priority patent/US4666885A/en
Priority claimed from US06/699,710 external-priority patent/US5023234A/en
Priority claimed from US06/699,711 external-priority patent/US4659695A/en
Application filed by Fernand Labrie filed Critical Fernand Labrie
Publication of DK147086A publication Critical patent/DK147086A/da
Publication of DK147086D0 publication Critical patent/DK147086D0/da
Application granted granted Critical
Publication of DK168516B1 publication Critical patent/DK168516B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK147086A 1984-08-02 1986-04-01 Sæt til kombinationsterapi af visse kønshormonafhængige cancertyper hos et varmblodet dyr DK168516B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US63688384 1984-08-02
US06/636,883 US4775660A (en) 1984-08-02 1984-08-02 Treatment of breast cancer by combination therapy
US69971085 1985-02-08
US06/699,702 US4666885A (en) 1985-02-08 1985-02-08 Combination therapy for treatment of female breast cancer
US69971185 1985-02-08
US06/699,710 US5023234A (en) 1985-02-08 1985-02-08 Combination male breast cancer therapy
US69970285 1985-02-08
US06/699,711 US4659695A (en) 1985-02-08 1985-02-08 Method of treatment of prostate cancer
PCT/US1985/001454 WO1986001105A1 (en) 1984-08-02 1985-08-02 Pharmaceutical composition for combination therapy of hormone dependent cancers
US8501454 1985-08-02

Publications (3)

Publication Number Publication Date
DK147086A DK147086A (da) 1986-04-01
DK147086D0 true DK147086D0 (da) 1986-04-01
DK168516B1 DK168516B1 (da) 1994-04-11

Family

ID=27505215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK147086A DK168516B1 (da) 1984-08-02 1986-04-01 Sæt til kombinationsterapi af visse kønshormonafhængige cancertyper hos et varmblodet dyr

Country Status (8)

Country Link
EP (1) EP0195015B1 (da)
JP (1) JPH0680016B2 (da)
AT (1) ATE75947T1 (da)
AU (1) AU594309B2 (da)
DE (2) DE3590389T1 (da)
DK (1) DK168516B1 (da)
IE (1) IE58836B1 (da)
WO (1) WO1986001105A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012488A (en) * 1987-07-31 1989-02-02 Syntex (U.S.A.) Inc. Combination therapy with lhrh antagonist analogs and 19nor progestational steroids
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
HU199694B (en) * 1988-05-10 1990-03-28 Innofinance Altalanos Innovaci Process for producing citostatic pharmaceutical compositions containing gonadoliberin derivatives
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5686465A (en) * 1988-10-31 1997-11-11 Endorecherche Inc. Sex steroid activity inhibitors
US5204337A (en) * 1988-10-31 1993-04-20 Endorecherche Inc. Estrogen nucleus derivatives for use in inhibition of sex steroid activity
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
ZA901847B (en) * 1989-03-10 1991-10-30 Endorecherche Inc Combination therapy for the treatment of estrogen sensitive diseases
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ATE230994T1 (de) * 1989-07-07 2003-02-15 Endorech Inc Methode zur behandlung androgenbedingter krankheiten
DE69034148T2 (de) * 1989-07-07 2005-06-30 Endorecherche Inc., Ste-Foy Kombinationstherapie zur Prophylaxe und/oder Behandlung von gutartiger prostatischer Hyperplasie
US4990538A (en) * 1989-08-23 1991-02-05 Harris Adrian L Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
UA35589C2 (uk) * 1992-05-21 2001-04-16 Андорешерш Інк. ІНГІБІТОРИ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ІНГІБУВАННЯ АКТИВНОСТІ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
JPH08253417A (ja) * 1995-02-28 1996-10-01 Eli Lilly & Co 脳又はｃｎｓのエストロゲン陽性腫瘍抑制用製剤
ZA961564B (en) * 1995-02-28 1997-08-27 Lilly Co Eli Methods of inhibiting ovarian cancer.
FR2736550B1 (fr) * 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
HUP0101809A3 (en) 1998-03-11 2002-07-29 Endorech Inc Sainte Foy Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
ATE498408T1 (de) * 2001-08-10 2011-03-15 Takeda Pharmaceutical Gnrh-agonistische kombinationsmittel
PE20030703A1 (es) 2001-09-06 2003-08-21 Schering Corp Inhibidores de la 17b-hidroxiesteroide deshidrogenasa tipo 3
EP1436281B1 (en) 2001-10-17 2010-06-16 Schering Corporation Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2004046111A1 (en) 2002-11-18 2004-06-03 Schering Corporation 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
DE60323765D1 (de) 2002-12-17 2008-11-06 Schering Corp Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
GB0513702D0 (en) 2005-07-04 2005-08-10 Sterix Ltd Compound
GB0722779D0 (en) 2007-11-20 2008-01-02 Sterix Ltd Compound
CN115862804B (zh) * 2022-11-25 2023-12-19 成都诺医德医学检验实验室有限公司 双药联用的联合用药的推荐方法及装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329364A (en) * 1974-09-11 1982-05-11 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
DE2921593C2 (de) * 1979-05-28 1984-02-02 Gränges Nyby AB, Nybybruk Verfahren und Vorrichtung zum Weiterzerkleinern von hydriertem, grobstückigem Material, insbes. Schrott aus Titan oder dessen Legierungen
ZA822247B (en) * 1981-04-03 1983-11-30 Lilly Co Eli Benzothiophene compounds and process for preparing them

Also Published As

Publication number Publication date
ATE75947T1 (de) 1992-05-15
DE3590389T1 (de) 1986-08-28
DK168516B1 (da) 1994-04-11
AU594309B2 (en) 1990-03-08
JPS62500451A (ja) 1987-02-26
EP0195015A1 (en) 1986-09-24
DE3586053D1 (de) 1992-06-17
JPH0680016B2 (ja) 1994-10-12
DK147086A (da) 1986-04-01
IE58836B1 (en) 1993-11-17
EP0195015B1 (en) 1992-05-13
IE851929L (en) 1986-02-02
WO1986001105A1 (en) 1986-02-27
AU4728285A (en) 1986-03-07

Similar Documents

Publication Publication Date Title
DK147086D0 (da) Farmaceutisk komposition til kombinationsterapi af hormonafhaengige cancertyper
DK0595796T3 (da) Fremgangsmåde til behandling af androgen-relaterede sygdomme
DK550188A (da) Antigestagen- og antioestrogenvirksomme forbindelser til behandling af hormonafhaengige tumorer
DK0462189T3 (da) Kombinationsterapi til behandling af østrogenfølsomme sygdomme
DK0971705T3 (da) Lægemiddelformuleringer til hormonerstatningsterapi til lokal påföring på huden
PT748190E (pt) Metodos e formulacoes para uso no tratamento de disturbios ginecologicos benignos
ES396288A1 (es) Procedimiento para la obtencion de composiciones cosmeticasabsorbentes de rayos ultravioletas.
DK1556058T3 (da) Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
ES2178188T3 (es) Composiciones antitusigenas que contienen teobromina.
DE59911734D1 (de) Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
PH16119A (en) New hydroxypropyl-triazole compound,their composition and medicinal use
PT1135169E (pt) Uso de uma composicao farmaceutica compreendendo um agente anti-canceroso e pelo menos um peptideo
NO169322C (no) Befruktningshindrende preparat med synergistisk virkning
EA200301129A1 (ru) Ингибирование ароматазы для улучшения вспомогательной репродукции
NZ510445A (en) A method for intrahepatic administration of methoxymorpholino doxorubicin (MMDX) to achieve a high concentration at a hepatic tumour site
ES2039373T3 (es) Esteroides utiles como agentes anticancerigenos y antiobesidad, una composicion terapeutica que los contiene y su uso para la preparacion de una composicion terapeutica.
DK1200107T3 (da) Præparater der har steroid östrogenvirkning, hvilke præparater ikke öger risikoen for brystcancer
DK174085D0 (da) Fremstilling af praeparater, indeholdende gonadoliberin og gonadoliberinagonister, og anvendelse deraf til behandling af klimakterielle besvaerligheder
DE69123573D1 (de) Synergistische zusammensetzungen
IT8548226A0 (it) Composizione per inibire lo sviluppo di tumori e procedimento per lasua preparazione
BG45693A3 (en) Zootechnical composition
EP0793499A4 (en) METHOD AND MEANS FOR REDUCING TUMOR DEVELOPMENT BY MEANS OF A COMBINATION OF A TAXAN COMPOUND AND A TELLUR AND / OR SELENIUM COMPOUND
ATE251459T1 (de) Verwendung von dienogest in hoher dosierung

Legal Events

Date Code Title Description
PBP Patent lapsed
B1 Patent granted (law 1993)
PUP Patent expired